Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | GNPAT | O15228 | 2/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.37 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.37 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | ALB | P02768 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3792833 | 1.00 | SMN1; SMN2 (0.50) | SMN1; SMN2MAPTKDM4ETHRBALOX15 | |
| SCHEMBL22612669 | 1.00 | SMN1; SMN2 (0.50) | SMN1; SMN2MAPTKDM4ETHRBALOX15 | |
| SCHEMBL29475246 | 0.87 | KDM4E (0.38) | SMN1; SMN2MAPTKDM4ETHRBALOX15 | |
| SCHEMBL7608409 | 0.87 | FOLH1 (0.38) | SMN1; SMN2MAPTKDM4ETHRBALOX15 | |
| SCHEMBL30804200 | 0.85 | SMN1; SMN2 (0.53) | SMN1; SMN2MAPTKDM4ETHRBALOX15 | |
| SCHEMBL14611803 | 0.84 | SIRT6 (0.41) | SMN1; SMN2MAPTKDM4ETHRBALOX15 | |
| SCHEMBL12537172 | 0.82 | ALDH1A1 (0.38) | SMN1; SMN2MAPTKDM4ETHRBALOX15 | |
| SCHEMBL20160296 | 0.82 | KDM4E (0.35) | SMN1; SMN2MAPTKDM4ETHRBALOX15 | |
| SCHEMBL31167431 | 0.81 | ACE (0.32) | SMN1; SMN2MAPTKDM4ETHRBALOX15 | |
| SCHEMBL20077217 | 0.81 | MAPT (0.53) | SMN1; SMN2MAPTKDM4ETHRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10385015-B2 | N-acylated methionine sulfoxides as food flavouring compounds | GIVAUDAN S.A. (CH) | 2019-08-20 | — | — | US | claimed |
| US-20170088512-A1 | N-ACYLATED METHIONINE SULFOXIDES AS FOOD FLAVOURING COMPOUNDS | GIVAUDAN S.A. (CH) | 2017-03-30 | — | — | US | claimed |
| US-20260068916-A1 | COMPOSITIONS COMPRISING A DIHYDROCHALCONE | GIVAUDAN SA (CH) | 2026-03-12 | — | — | US | disclosed |
| US-20260026536-A1 | COMPOSITIONS COMPRISING A DIHYDROCHALCONE | GIVAUDAN SA (CH) | 2026-01-29 | — | — | US | disclosed |
| US-20250366502-A1 | COMPOSITIONS CONTAINING BRAZZEIN | GIVAUDAN SA (CH) | 2025-12-04 | — | — | US | disclosed |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
| US-20250255332-A1 | COMPOSITIONS COMPRISING AROMADENDRIN 3-ACETATE | GIVAUDAN SA (CH) | 2025-08-14 | — | — | US | disclosed |
| WO-2025093498-A1 | COMPOSITIONS COMPRISING A MOGROSIDE | GIVAUDAN SA (CH) | 2025-05-08 | — | — | WO | disclosed |
| WO-2025093497-A1 | COMPOSITIONS COMPRISING A DIHYDROCHALCONE | GIVAUDAN SA (CH) | 2025-05-08 | — | — | WO | disclosed |
| EP-4539677-A2 | COMPOSITIONS CONTAINING BRAZZEIN | Givaudan SA (CH) | 2025-04-23 | — | — | EP | disclosed |
| CN-119768065-A | Composition comprising amyrin 3-acetate | 奇华顿股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| WO-2007112433-A2 | COMPOSITIONS FOR PROMOTING HAIR GROWTH | NOVUS INTERNATIONAL INC. (US) | 2007-10-04 | — | — | WO | disclosed |
| US-20070072935-A1 | Catalytic antioxidants and methods of use | FLORIDA ATLANTIC UNIVERSITY (US) | 2007-03-29 | — | — | US | disclosed |
| US-7129374-B2 | Catalytic antioxidants and methods of use | FLORIDA ATLANTIC UNIVERSITY (US) | 2006-10-31 | — | — | US | disclosed |
| US-20040143016-A1 | Catalytic antioxidants and methods of use | FLORIDA ATLANTIC UNIVERSITY RESEARCH CORPORATION | 2004-07-22 | — | — | US | disclosed |
| WO-2004047772-A2 | CATALYTIC ANTIOXIDANTS AND METHODS OF USE | FLORIDA ATLANTIC UNIVERSITY (US) | 2004-06-10 | — | — | WO | disclosed |
| US-5952186-A | QUANTITATIVE ANALYSIS OF METHIONINE SULFOXIDE IN PEPTIDE OR PROTEIN SAMPLE BY MIXING WITH METHIONINE REDUCTASE IN PRESENCE OF REDUCING AGENT HAVING SULFHYDRYL GROUP AND REPORTER TAG, DETECTING AMOUNT OF OXIDIZED REDUCING AGENT | PROMEGA CORPORATION (US) | 1999-09-14 | — | — | US | disclosed |
| EP-0900284-A1 | NOVEL REAGENT, METHOD, AND KIT FOR THE QUANTITATION OF OXIDATION-REDUCTION PHENOMENA IN PROTEINS AND PEPTIDES | PROMEGA CORPORATION (US) | 1999-03-10 | — | — | EP | disclosed |
| WO-1997039141-A1 | NOVEL REAGENT, METHOD, AND KIT FOR THE QUANTITATION OF OXIDATION-REDUCTION PHENOMENA IN PROTEINS AND PEPTIDES | PROMEGA CORPORATION (US) | 1997-10-23 | — | — | WO | disclosed |
| WO-1995014929-A1 | DIMERIC OLIGOPEPTIDE MIXTURE SETS | HOUGHTEN PHARMACEUTICALS, INC. (US) | 1995-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10385015-B2 | N-acylated methionine sulfoxides as food flavouring compounds | MTR, MGMT, TAS1R1 | SMN1; SMN2 249/4885MAPT 3192/4885KDM4E 1601/4885 |
| US-20070072935-A1 | Catalytic antioxidants and methods of use | MSRB3, GSR, PRDX3 | SMN1; SMN2 3367/4885MAPT 4130/4885KDM4E 1336/4885 |
| US-20260026536-A1 | COMPOSITIONS COMPRISING A DIHYDROCHALCONE | TAS2R50, TAS2R5, TAS2R40 | SMN1; SMN2 3119/4885MAPT 3336/4885KDM4E 132/4885 |
| US-20040143016-A1 | Catalytic antioxidants and methods of use | MSRB3, GSR, PRDX3 | SMN1; SMN2 3367/4885MAPT 4130/4885KDM4E 1336/4885 |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | SMN1; SMN2 261/4885MAPT 953/4885KDM4E 3958/4885 |
| US-20170088512-A1 | N-ACYLATED METHIONINE SULFOXIDES AS FOOD FLAVOURING COMPOUNDS | MTR, MGMT, TAS1R1 | SMN1; SMN2 249/4885MAPT 3192/4885KDM4E 1601/4885 |
| US-20260068916-A1 | COMPOSITIONS COMPRISING A DIHYDROCHALCONE | TAS2R20, TAS2R50, TAS2R40 | SMN1; SMN2 3683/4885MAPT 3410/4885KDM4E 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.